[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:e3-ubiquitin-protein-ligase-xiap":3},{"name":4,"total":5,"recruiting":5,"trials":6},"E3 Ubiquitin-Protein Ligase XIAP",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06160791","Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)",[11],"Phase 2","RECRUITING","2026-08-26T02:14:59.425132Z","2026-05-05T02:43:29.166290Z"]